Health Care • Medical/Dental Instruments
$1.57 ▲ +0.01
(+0.64%)
MKT CAP: $50.5M • VOL: 67.9K
52W L $1 52W H $3
MDAI // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $19.6M | $29.6M | $18.1M |
| YoY Revenue Growth % | -33.6% | +63.8% | — |
| Gross Profit | $8.9M | $13.3M | — |
| Gross Margin % | 45.4% | 44.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$8.6M | -$6.6M | -$13.0M |
| Operating Margin % | -43.8% | -22.3% | -71.9% |
| Net Income (GAAP) | -$7.6M | -$15.2M | -$20.9M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$9.9M | -$9.2M | -$13.2M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | -$9.9M | -$9.2M | -$13.2M |
| FCF Margin % | -50.5% | -31.1% | -73.3% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $15.4M | $5.2M | — |
| Total Debt (Short + Long Term) | $5.5M | — | — |
| Total Stockholders' Equity | -$5.7M | -$7.3M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR MDAI.